Health Canada has commenced a review of its Industrial Hemp Regulations (IHR), seeking feedback on potential amendments aimed at streamlining the regulatory framework. This initiative, detailed in a Notice of Intent posted on May 15, 2026, is part of the Canadian government’s broader efforts to reduce administrative burdens across various sectors. The review specifically targets aspects of the industrial hemp regulations that may impose high regulatory requirements disproportionate to the limited public health and safety risks associated with industrial hemp, which is legally defined by a tetrahydrocannabinol (THC) concentration below 0.3% by weight.
Rationale for Regulatory Streamlining
The stated objective of Health Canada’s review is to reform the existing framework for industrial hemp growers and processors. The agency acknowledges that industrial hemp presents significantly lower risks compared to cannabis due to its minimal THC content. This recognition underpins the drive to identify and implement changes that could simplify the regulations, mirroring adjustments made to the Cannabis Act in 2025.
Key areas under consideration for potential changes to the IHR include:
- Eliminating or reducing specific regulatory requirements.
- Decreasing administrative burden for licence holders.
Despite the push for simplification, Health Canada has indicated that controls will remain in place to prevent the diversion of licensed industrial hemp activities for illicit cannabis production and to ensure compliance with international obligations.
Public Consultation Process
The Notice of Intent initiates a 45-day public comment period, which commenced on May 15, 2026, and is scheduled to conclude on June 30, 2026. During this period, interested parties are invited to provide feedback on the proposed amendments. Industrial hemp licence holders are also requested to complete a cost-benefit analysis questionnaire. This feedback will contribute to a Regulatory Impact Analysis Statement (RIAS), which, if regulatory changes are proposed, will subsequently be published in the Canada Gazette.
Overview of Canadian Industrial Hemp Sector
Industrial hemp production has been legally permitted in Canada since 1998. Commercial activities involving the growing, selling, importing, exporting, cleaning, and processing of hemp seed, grain, fibre, and chaff (flowers, leaves, and stems) typically require an industrial hemp licence. Historically, Canadian hemp farmers have concentrated on producing seed for specialty food markets, partly due to a lack of established infrastructure for broader industrial applications.
According to Health Canada’s most recent available figures, as of October 15, 2024, the sector comprised 737 Industrial Hemp Licenses across Canada, with 643 specifically designated for cultivation. For the 2026 growing season, 93 hemp cultivars have received approval for commercial production. Geographically, Ontario holds the largest number of licences at 176, followed by Alberta with 142, and Quebec with 116. These licences collectively account for 15,588.23 hectares approved for cultivation nationwide.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Hemp Gazette does not provide medical recommendations, diagnoses, or treatment plans. Always consult a qualified healthcare practitioner before making any decisions regarding your health or any medical condition. Statements concerning the therapeutic uses of hemp, cannabis, or cannabinoid-derived products have not been evaluated by Australia’s Therapeutic Goods Administration (TGA). Medicinal cannabis products in Australia are accessed via prescription pathways under TGA regulation.
